Unbound bilirubin: a call to reframe neonatal care and clinical decision-making. [PDF]
Pediatr ResHegyi T.
europepmc +1 more source
Severe neonatal hyperbilirubinemia in infants aged 60 days or less (2025 to 2027). [PDF]
Paediatr Child HealthSgro M +4 more
europepmc +1 more source
Prevalence, aetiology, and treatment needs of neonates with G6PD deficiency in Central Peninsular Malaysia. [PDF]
Sci RepZailani MAH +5 more
europepmc +1 more source
Advances in laboratory diagnosis of neonatal hyperbilirubinemia and peculiarities in plateau regions: a review of evidence. [PDF]
Front PediatrTang C, Xia L, Xu D.
europepmc +1 more source
Risk Factors and Clinical Outcomes of Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates: A Case-Control Study. [PDF]
CureusFatima UB +5 more
europepmc +1 more source
Neurodevelopmental Outcomes in Term Infants with Neonatal Hyperbilirubinaemia in China: A Retrospective Cohort Study Using the Griffiths Developmental Scales. [PDF]
J Clin MedMa Y +6 more
europepmc +1 more source
An Interpretable Machine Learning Model for Predicting Intellectual Disability in Children With Cerebral Palsy. [PDF]
J Intellect Disabil ResMa D, Wang Y.
europepmc +1 more source
Comparing Neurodevelopmental Outcome among Neonates with Jaundice Due to ABO and Rh Incompatibility. [PDF]
Iran J Child NeurolBoskabadi H +4 more
europepmc +1 more source
The assessment of risk factors for cerebral palsy should also include genetic testing, especially if parents are consanguineous. [PDF]
Sudan J PaediatrWalter S, Finsterer J.
europepmc +1 more source
Docosahexaenoic acid attenuates neuropathological alterations in a rodent model of neonatal bilirubin-induced encephalopathy. [PDF]
Front Med (Lausanne)Yao Y +5 more
europepmc +1 more source